COMMUNIQUÉS West-GlobeNewswire

Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
11/07/2019
Company provides insights on commercial activities in anticipation of Metastron™/Strontium-89 launch expected later this year NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage [...]
Marrone Bio Innovations and Valagro announce research collaboration
11/07/2019
New research collaboration to develop innovative bio-based products to increase crop yields and quality ATESSA, Italy and DAVIS, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc . (the “Company” or [...]
Epigenomics AG Receives MedTech Outlook's 2019 Top 10 In-Vitro Diagnostics Award
11/07/2019
- Company recognized for its leadership in advancing blood-based tests to diagnose cancer - BERLIN and SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced [...]
Hemostemix Announces Financing Update and Interim CFO Appointment
11/07/2019
CALGARY, Alberta, July 11, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and commercializing innovative [...]
Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare
11/07/2019
SCOTTSDALE, Ariz., July 11, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com ), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self [...]
REPEAT - AgraFlora Organics “THC Antidote” to Feature Endorsement From Famed Celebrity Cannabis Activist; Provides Guidance Regarding Nano-Encapsulated Delivery System
11/07/2019
VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Dr. Seth Forman to Chair XBiotech’s Second Phase 2 Study of Bermekimab in Atopic Dermatitis
11/07/2019
Upcoming randomized, double-blind, placebo controlled Phase 2 study follows recent successful open label study in Atopic Dermatitis (AD) AUSTIN, Texas, July 11, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announces [...]
Novan SB206 Phase 3 Molluscum Pivotal Program Update
11/07/2019
More than 50 percent of total expected patients now enrolled Virtually all of the clinical sites now active Discipline and execution focus remain of equal importance to recruitment activity MORRISVILLE, N.C., July 11, [...]
iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval
11/07/2019
Deep-learning, artificial intelligence technology assists radiologists in detecting breast cancer NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel
11/07/2019
REDWOOD CITY, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today [...]
NeuBase Therapeutics to Participate in Roth RNA Revolution Conference
11/07/2019
PITTSBURGH, July 11, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address genetic diseases, today announced that Dietrich [...]
Alder BioPharmaceuticals® Presents New Data on Migraine-Free Months, Migraine Severity and Quality of Life, Demonstrating Eptinezumab’s Clinical Profile for Migraine Prevention
11/07/2019
- Posters presented at the 2019 American Headache Society meeting highlight eptinezumab’s safety profile and suppression of calcitonin gene-related peptide (CGRP) - - New data show no migraine days experienced for six [...]
Avricore Health Announces Amendment to Placement Terms
11/07/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
CareDx Applauds White House Efforts to Reform America’s Kidney Health System
11/07/2019
Executive Order outlines initiatives to make organ transplantation the preferred treatment option BRISBANE, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company [...]
Manasi Patwardhan Joins BioSig as Director of Strategic Planning
11/07/2019
BioSig enhances operational excellence through talent acquisition in program management and strategic planning from Fortune 500 background Westport, CT, July 11, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents
11/07/2019
SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced [...]
Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility
11/07/2019
Facility Advances Partnership with Ginkgo Bioworks; Will Enable Production of Cultured Cannabinoids at Commercial Scale TORONTO, July 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos [...]
Theratechnologies Announces Financial Results for the Second Quarter of 2019
11/07/2019
MONTREAL, July 11, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the second quarter ended May 31, 2019. Second quarter 2019 financial highlights [...]
Theratechnologies annonce ses résultats financiers pour le deuxième trimestre de 2019
11/07/2019
MONTRÉAL, 11 juill. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le deuxième trimestre clos le 31 mai 2019. Faits saillants [...]

Pages